Regulation by beta-adrenoceptor subtypes of cardiac function : Analysis by selective beta agonists
Regulation by beta-adrenoceptor subtypes of cardiac function : Analysis by selective beta agonists
批准号:
02454485
负责人:
NAGAO Taku
金额:
$4.03万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
本研究旨在建立地诺帕明的儿茶酚衍生物T-0509作为选择性β_1全激动剂,并利用选择性β受体激动剂研究心脏肌肉中β-肾上腺素能受体亚型的功能意义。与异丙肾上腺素相比,T-0509对β_1肾上腺素受体的选择性几乎与异丙肾上腺素相当,对β_2肾上腺素受体的选择性是β_2肾上腺素受体的150倍。(1)在豚鼠心脏中,我们发现了cAMP的亚细胞部分,它与多种cAMP依赖药的正性变力作用(PIE)密切相关。在这一组分中,A激酶活性也与PIE密切相关。(2)在豚鼠心室肌中,β-受体激动剂的PIE可通过β_1-肾上腺素能受体的钙电流增加来解释。(3)β-全激动剂可引起大鼠慢性给药脱敏,但以往研究中使用的剂量极高,用来研究β-受体亚型在体内的影响。我们正在研究选择性β_1激动剂与非选择性β_1激动剂相比导致弱脱敏的可能性。(4)犬冠状动脉有β-肾上腺素能受体。我们发现,即使在生理条件下,β_1全激动剂也可能通过β_1肾上腺素能受体引起微小但显著的冠状动脉扩张。
英文摘要
This study was aimed to establish T-0509, the catechol derivative of denopamine, as selective beta_1 full agonist and to study functional significance of beta-adrenoceptor subtypes in the ventricular muscle of the heart using selective beta agonists.First we established the catechol derivative of denopamine (T-0509) as a selective beta_1 full agonist using isolated tissues and radioligand binding assay. T-0509 is almost as potent as isoproterenol and 150 times more selective to beta_1-adrenoceptors than beta_2- adrenoceptors as compared with isoproterenol.Following results were obtained using T-0509. (1) In the guinea pig heart, we found a subcellular fraction of cAMP which closely relates to the positive inotropic effects (PIE) of various cAMP-dependent agents. In this fraction, A kinase activity also closely related to PIE. (2) In the guinea pig ventricular muscle, PIE of beta full agonists can be explained by an increase in Ca^<2+> current via beta_1-adrenoceptors. (3) The beta full agonist causes desensitization by chronic administration to rats, but the doses used in previous studies were found to be extremely high to study the influence of beta-adrenoceptor subtypes in vivo. We are studying the possibility that selective beta_1 agonist causes weak desensitization as compared with non-selective beta agonists. (4) The beta-adrenoceptor has been shown in canine coronary artery. Wefound the possibility that beta_1 full agonist causes small but significant coronary vasodilation via beta_1-adrenoceptors even in the physiological condition.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Sugimoto,H.Yabana,J.Yamazaki&T.Nagao: "The role of β-adrenoceptor subtypes on coronary blood flow in anesthetized open-chest dogs." Japanese Journal of Pharmacology. 55. 332 (1991)
T.Sugimoto、H.Yabana、J.Yamazaki 和 T.Nagao:“β-肾上腺素受体亚型对麻醉开胸犬冠状动脉血流的作用”,《日本药理学杂志》55. 332 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yabana;H.Watanabe;H.Narita;T.Nagao: "Selective and full β_1ーadrenoceptor agonist action of a catechol derivative of denopamine(Tー0509)in the guinea pig candiac muscle and trachea:comparison with denopamine,xamolerol and isoprenaline" British Journal of
H.Yabana;H.Watanabe;H.Narita;T.Nagao:“地诺帕明儿茶酚衍生物 (T-0509) 对豚鼠念珠肌和气管的选择性和完全 β_1-肾上腺素能受体激动作用:与地诺帕明、沙莫罗尔的比较和异丙肾上腺素”英国杂志
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Sugimoto;H.Yabana;J.Yamazaki;T.Nagao: "The role of βーadrenoceptor subtypes on coronary blood flow in anesthetized openーchest clogs" Japanese Journal of Pharmacology. 55. 332 (1991)
T.Sugimoto;H.Yabana;J.Yamazaki;T.Nagao:“β-肾上腺素受体亚型对麻醉开胸木屐中冠状动脉血流的作用”《日本药理学杂志》55. 332 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Narita,M.Gaino T.Suzuki,T.Nagao: "Synthesis and Pharmacological Properties of Azido Derivatives of 1.5ーBenzothiazepine Ca Antagonist" Chem.Pharm.Bull.38. 407-410 (1990)
H.Narita,M.Gaino T.Suzuki,T.Nagao:“1.5-苯并硫氮卓 Ca 拮抗剂的叠氮衍生物的合成和药理学特性”Chem.Pharm.Bull.38 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Sasaki,H.Yabana,T.Nagao,S.Takeyama: "Compartmentalized elevation of cyclicーAMP by denopamine in the isolated perfused guineaーpig heart" Journal of Applied Cardiology. 5. 3-12 (1990)
Y.Sasaki、H.Yabana、T.Nagao、S.Takeyama:“在离体灌注豚鼠心脏中地诺帕明对环 AMP 的区室化升高”应用心脏病学杂志 5. 3-12 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Novel Therapeutic Strategy for Heart Failure : Molecular Mechanism underlying the Regulation of Ca^<2+> Signaling in the Heart
-
批准号:13307065
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$34.86万
-
财政年份:2001
-
负责人:NAGAO Taku
-
依托单位:
Role of receptor kinase in β1-adrenergic receptor signaling, and hypertrophy/heart failure
-
批准号:11557189
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$7.3万
-
财政年份:1999
-
负责人:NAGAO Taku
-
依托单位:
Study on regulatory mechanism for cardiac contraction : seeking for therapeutic basis of heart failure.
-
批准号:10307056
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$20.93万
-
财政年份:1998
-
负责人:NAGAO Taku
-
依托单位:
Establishment of Functional Analysis by Expressing Antibody Molecule in the Cells
-
批准号:07557151
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1995
-
负责人:NAGAO Taku
-
依托单位:
Analysis of effects of Ca-antagonists in pathophysiological models
-
批准号:04454530
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1992
-
负责人:NAGAO Taku
-
依托单位: